News
Aon plc (NYSE:AON) is one of the 12 Best Stocks to Invest in for Good Returns. On July 7, Barclays lowered the price target ...
AbbVie’s projected 2025 earnings just got trimmed by Cantor Fitzgerald, slicing estimates from $12.31 per share to $11.84.
VFLO applies a free cash flow strategy with a sector tilt toward energy and healthcare, offering value at a discount. Find ...
Verona Pharma plc (NASDAQ:VRNA) is one of the 11 Best Mid-cap Healthcare Stocks to Buy According to Hedge Funds.
Beyond the short-term market impacts of trade tensions and geopolitical risk events, we are constructive in our medium-term ...
Cargo theft recording firms offer tips on how trucking companies, drivers and others in the supply chain can protect cargo ...
Public Storage (NYSE:PSA) is one of the most undervalued stocks. On June 13, JPMorgan reiterated an Overweight rating on PSA, ...
"Global growth is slowing, but macro is not the markets," Morgan Stanley wrote in recent research.
Investing.com - Piper Sandler has reiterated an Overweight rating and $328.00 price target on Amgen (NASDAQ:AMGN) following the company’s release of detailed MariTide tolerability data. The market ...
On Monday, May 19, Morgan Stanley maintained its Overweight rating on NVIDIA Corporation (NASDAQ:NVDA) with a price target of $160. The firm’s analysts highlighted the company’s recent ...
Additionally, Cantor Fitzgerald reaffirmed its Overweight rating on Summit Therapeutics, noting the early exercise of warrants by co-CEO and Chairman Bob Duggan as a positive indicator.
Friday - JPMorgan analysts have maintained their Overweight rating on Luminar Technologies (NASDAQ:LAZR) shares, while reiterating the $90.00 price target. According to InvestingPro data, the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results